Angioimmunoblastic
T-Cell Lymphoma
Treatment Options
Patients with AITL may be treated with a steroid that can temporarily relieve the symptoms caused by the immune system’s reaction to the cancer cells, such as joint inflammation or pain and skin rash.
Recommended first-line therapy is either a clinical trial or a multiagent chemotherapy regimen, such as CHOP (cyclophosphamide doxorubicin, vincristine, and prednisone). Sometimes higher doses of chemotherapy followed by stem cell transplantation may be added to multiagent chemotherapy.
Several drugs have been tested in small clinical trials (alone or in combination with current chemotherapy regimens) and show promise for the treatment of AITL, including:
- Brentuximab vedotin (Adcetris)
- Lenalidomide (Revlimid)
- Panobinostat (Farydak)
Learn More
To learn more about AITL, download the Angioimmunoblastic T-Cell Lymphoma Fact Sheet. Want to talk to someone? For answers to lymphoma-related questions and resources, contact our Helpline at (800) 500-9976 or helpline@lymphoma.org.

Additional Resources
To learn more about ATLL, download the Adult T-Cell Leukemia/Lymphoma Fact Sheet.
Events

Ask the Doctor: Information for Relapsed/Refractory Patients
VirtualAsk the Doctor About Lymphoma is a virtual two-hour program that combines a comprehensive and […]

Pregunte al doctor sobre el linfoma
Pregúnte al Doctor sobre el linfoma es un programa virtual de dos horas que combina […]

Lymphoma Talk: Los Angeles
Westdrift Manhattan Beach 1400 Parkview Avenue, Manhattan Beach, CaliforniaLymphoma Talk is a two-hour weekday evening in-person program led by lymphoma experts that provides […]